Inhibitor Therapeutics Inc. financial statements
Inhibitor Therapeutics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Net income | −USD 3.3M | 10-K |
| Cash and equivalents | USD 2.38M | 10-Q |
| Total debt | USD 24.72K | 10-Q |
Inhibitor Therapeutics Inc. financials on 6ix · Inhibitor Therapeutics Inc. on 6ix